Protein tyrosine kinases from the human epidermal growth factor receptor family, such as EGFR and HER2, are important therapeutic targets for many malignancies, including non-small cell lung cancer, breast cancer, and gastroesophageal cancer, particularly colorectal cancer (4). Here, EGFR is linked to breast carcinoma.